Modern clinical trials for heart failure therapies significantly under-represent women, the elderly, and patients with advanced chronic kidney disease, highlighting a need for targeted prospective research.
This review highlights the critical underrepresentation of older patients, women, and those with advanced chronic kidney disease in modern heart failure clinical trials.
Heart failure and chronic kidney disease are common conditions and often coexist. Modern clinical trials are not entirely representative of heart failure patients in the community with respect to age and sex. Despite this, another group of heart failure patients, those with advanced chronic kidney disease, are even less represented in modern clinical trials. This review summarises the evidence for heart failure therapies across age, sex and severity of chronic kidney disease, and outlines the need for further research in these populations.
Parmar et al. (Wed,) conducted a editorial in Heart failure and chronic kidney disease. Modern clinical trials for heart failure therapies significantly under-represent women, the elderly, and patients with advanced chronic kidney disease, highlighting a need for targeted prospective research.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: